Most Read Articles
Dr. Joseph Delano Fule Robles, 5 days ago

A recent study conducted by The University of Hong Kong (HKU) revealed that long-term use of proton pump inhibitors (PPIs) is associated with a significantly increased risk of gastric cancer even in patients who have had Helicobacter pylori eradicated. 

23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Mar 2014
Pharmacologic methods to relieve symptoms of dysmenorrhea are linked to various side effects, thus, non-pharmacologic interventions have a significant potential value.

Benzodiazepine linked to increased risk of pneumonia

Elaine Soliven
18 Apr 2017

Benzodiazepine use appears to be associated with increased risk of pneumonia among patients with Alzheimer’s disease, according to a recent study.

Researchers analysed data from the MEDALZ* cohort including 49,484 patients (mean age 80 years, 62.7 percent female) diagnosed with Alzheimer’s disease. Of these, 5,232 patients were taking benzodiazepines (ie, alprazolam, chlordiazepoxide, clobazam, diazepam, lorazepam, nitrazepam, oxazepam, and temazepam), while 3,269 patients were taking non-benzodiazepines or Z-drugs (ie, zolpidem and zopiclone), and were matched 1:1 with nonusers. [CMAJ 2017;doi:10.1503/cmaj.160126]

Using propensity score-matched analysis, the rate of pneumonia was higher in both benzodiazepine and Z-drug users compared with nonusers (events per 100 person-years, 8.10, 95 percent confidence interval [CI], 8.03–8.16 vs 6.32, 95 percent CI, 6.28–6.35).

Collectively, benzodiazepine and Z-drug use was associated with an increased risk of pneumonia in patients with Alzheimer’s disease (adjusted hazard ratio [adjHR], 1.22, 95 percent CI, 1.05–1.42).

However, on separate analysis, an increased risk of pneumonia was associated with benzodiazepine use (adjHR, 1.28, 95 percent CI, 1.07–1.54) but not with Z-drug use (adjHR, 1.10, 95 percent CI, 0.84–1.44).

“One possible explanation for the increased risk of pneumonia associated with benzodiazepine use may be related to the more pronounced sedative effects of these drugs in this population. Sedation may increase risk of aspiration, which may lead to pneumonia,” according to the researchers.

Of note was the higher risk of pneumonia associated with benzodiazepine during the first 30 days of use (hazard ratio, 2.09, 95 percent CI, 1.26–3.48).

“[S]edation is more pronounced at the start of use before tolerance develops,” they said, noting that this could account for the increased risk of pneumonia at the beginning of drug use.

Overall, the findings are consistent with previous studies associating benzodiazepine use with an increased risk of pneumonia as well as respiratory exacerbations and emergency department visits for COPD or pneumonia patients. [Thorax 2013;68:163-170; Eur Respir J 2014;44:332-340]

“[The] benefits and risks of the use of benzodiazepines should be carefully considered for patients with Alzheimer’s disease and include risk of pneumonia,” said the researchers, who called for further investigation to determine other pharmacological mechanisms that could verify the association between respiratory adverse events and use of benzodiazepines and Z-drugs.

*MEDALZ: Medication use and Alzheimer’s disease

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 5 days ago

A recent study conducted by The University of Hong Kong (HKU) revealed that long-term use of proton pump inhibitors (PPIs) is associated with a significantly increased risk of gastric cancer even in patients who have had Helicobacter pylori eradicated. 

23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Mar 2014
Pharmacologic methods to relieve symptoms of dysmenorrhea are linked to various side effects, thus, non-pharmacologic interventions have a significant potential value.